Recurrent Colon Carcinoma Active Not Recruiting Phase 2 Trials for Oxaliplatin (DB00526)

Also known as: Carcinoma colon recurrent / Colon carcinoma recurrent / Colon cancer recurrent

IndicationStatusPhase
DBCOND0047445 (Recurrent Colon Carcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04294264TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon CancerTreatment